These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 576372)

  • 81. [A clinical study on the characteristics of galactorrhea-amenorrhea (especially of drug-induced galactorrhea-amenorrhea].
    Onda H
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1851-60. PubMed ID: 6438254
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Bromocriptine mesylate (Parlodel) in the management of amenorrhea/galactorrhea associated with hyperprolactinemia.
    Cuellar FG
    Obstet Gynecol; 1980 Mar; 55(3):278-84. PubMed ID: 6987580
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Clinical and endocrinological analyses of patients with galactorrhea and menstrual disorders due to sulpiride or metoclopramide.
    Aono T; Shioji T; Kinugasa T; Onishi T; Kurachi K
    J Clin Endocrinol Metab; 1978 Sep; 47(3):675-80. PubMed ID: 122411
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Significance of hyperprolactinemia in 70 women with amenorrhea.
    Potashnik G; Bar-Ziv J; Glick S; Shoham A; Ben-Aderet N
    Isr J Med Sci; 1978 Jul; 14(7):753-61. PubMed ID: 681167
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Results of treatment of galactorrhea-amenorrhea syndrome with bromocryptine (Parlodel)].
    Dudkiewicz J; Blecharz A; Kosowicz J
    Endokrynol Pol; 1978; 29(3):181-90. PubMed ID: 566660
    [No Abstract]   [Full Text] [Related]  

  • 86. The amenorrhoea-galactorrhea syndrome: present diagnostic and therapeutic perspectives.
    Venturini PL; Capitanio GL; Boccardo E; Ferraro R; Rossato P; De Cecco L
    Acta Eur Fertil; 1975 Dec; 6(4):331-8. PubMed ID: 1243606
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Restoration of ovarian function in patients with the amenorrhea-galactorrhea syndrome after long-term therapy with L-dopa.
    Zárate A; Canales ES; Jacobs LS; Maneiro PJ; Soria J; Daughaday WH
    Fertil Steril; 1973 May; 24(5):340-4. PubMed ID: 4735421
    [No Abstract]   [Full Text] [Related]  

  • 88. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Galactorrhea and hyperprolactinemia.
    Sakiyama R; Quan M
    Obstet Gynecol Surv; 1983 Dec; 38(12):689-700. PubMed ID: 6361641
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Drugs that affect the breast and lactation.
    Dickey RP; Stone SC
    Clin Obstet Gynecol; 1975 Jun; 18(2):95-111. PubMed ID: 1095275
    [TBL] [Abstract][Full Text] [Related]  

  • 91. PRL action on E2 ovarian secretion.
    Polatti F; Nava C; Brambilla A; Zara C
    Clin Exp Obstet Gynecol; 1982; 9(3):160-4. PubMed ID: 6819897
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Letter: Bromergocryptine and the galactorrhea-amenorrhea syndrome.
    Stempel LE
    Ann Intern Med; 1976 Sep; 85(3):401-3. PubMed ID: 962235
    [No Abstract]   [Full Text] [Related]  

  • 93. Long-term follow-up of women with amenorrhea-galactorrhea treated with bromocriptine.
    Tartagni M; Nicastri PL; Diaferia A; Di Gesù I; Loizzi P
    Clin Exp Obstet Gynecol; 1995; 22(4):301-6. PubMed ID: 8777784
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Study on galactorrhea-amenorrhea syndrome (GAS) with special reference to normoprolactinemic GAS].
    Imai T; Yasuda K; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1988 Jan; 64(1):1-15. PubMed ID: 3132404
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Clinical and endocrine features of hyperprolactinaemic amenorrhoea.
    Jacobs HS; Franks S; Murray MA; Hull MG; Steele SJ; Nabarro JD
    Clin Endocrinol (Oxf); 1976 Sep; 5(5):439-54. PubMed ID: 825329
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Study of the action of bromocriptine in hyperprolactinemic states. Results of a cooperative trial in 135 patients].
    Fossati P; Strauch G; Tourniaire J
    Nouv Presse Med; 1976 Jul 3-10; 5(27):1687-91. PubMed ID: 986640
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effect of acute administration of L-dopa on serum concentrations of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in patients with the amenorrhea-galactorrhea syndrome.
    Zárate A; Canales ES; Soria J; Maneiro PJ; MacGregor C
    Neuroendocrinology; 1973; 12(6):362-5. PubMed ID: 4796782
    [No Abstract]   [Full Text] [Related]  

  • 98. Raised serum prolactin levels in amenorrhoea.
    Seppălă M; Hibroven E; Ranta T; Virkkunen P; Leppăluoto J
    Br Med J; 1975 May; 2(5966):305-6. PubMed ID: 1093605
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The natural history of idiopathic hyperprolactinemia.
    Martin TL; Kim M; Malarkey WB
    J Clin Endocrinol Metab; 1985 May; 60(5):855-8. PubMed ID: 3980670
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Bromocriptine treatment of infertile women with amenorrhoea--galactorrhoea].
    Nillius SJ; Skarin O
    Lakartidningen; 1977 Nov; 74(46):4110-2. PubMed ID: 926944
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.